Big Molecule Watch
- Biocon’s Pertuzumab Biosimilar Receives Positive CHMP Opinion Under EMA’s Tailored Clinical Approach October 7, 2026 Yoko Bian
- Janssen Granted Preliminary Injunction Against Golimumab Biosimilar October 5, 2026 Wendy Leben|Emma Murray
- STADA and SBP Group Launch Biosimilars Partnership October 5, 2026 Michael Shriner
- USPTO Institutes Four IPRs Challenging Janssen’s Golimumab Method-of-Treatment Patents September 28, 2026 Grace Truong
- Dualitas Therapeutics and Roche Enter Research Collaboration to Discover and Develop Bispecific Antibodies September 28, 2026 Zachariah Holmes
- GSK to Acquire Trispecific T Cell-Engager for Multiple Myeloma from Chimagen Biosciences September 28, 2026 Zachariah Holmes
- Ultragenyx’s FAYUVI Becomes First FDA-Approved Treatment for Sanfilippo Syndrome Type A September 25, 2026 Alison Siedor
- Parties Dispute Intent Standard in STELARA® Antitrust Appeal September 22, 2026 Harrison Gunn
- BMS and Ono File BPCIA Suit Against Amgen for Nivolumab Biosimilar September 18, 2026 Alice Yoon
- Cipla and Qilu Announce Exclusive U.S. Licensing and Supply Agreement for Pembrolizumab Biosimilar September 15, 2026 Sam Herron